Acupuncture and Integrative Care in Gynecological Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03560388 |
|
Recruitment Status :
Recruiting
First Posted : June 18, 2018
Last Update Posted : August 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Quality of Life | Other: Acupuncture and touch/relaxation | Not Applicable |
Patients undergoing surgical procedures for gynecological cancer are frequently challenged by intense anxiety prior to surgery, reflecting the accompanying uncertainty regarding the diagnosis, treatment and prognosis of their illness. Following operation, pain and other quality of life-related concerns further exacerbate the emotional distress, which may itself aggravate pain and other symptoms. Clinical, controlled studied among patients with gynecological cancer undergoing chemotherapy had demonstrated effectiveness of complementary and integrative medicine (CIM) treatments for improving quality of life (QOL) and related symptoms, such as pain, gastro-intestinal concerns, fatigue, and anxiety.
The purpose of the proposed study is to explore the impact of CIM treatments (including acupuncture) on anxiety, pain, and general QOL of patients referred to gynecological oncology surgery. The investigators' working hypothesis is that an intensive CIM treatment program, provided to patients within 24 hours prior to and during surgery will reduce perioperative anxiety and pain, and will reduce the need for intra-operative and post-operative analgesia.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 135 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Two main arms of control and intervention. Intervention arm include two sub-arms of integrative treatment plus acupuncture vs. integrative treatment with no acupuncture |
| Masking: | Triple (Participant, Care Provider, Investigator) |
| Masking Description: | Participant, care provider, and investigator are blind to allocation to control vs. intervention groups. Participant is also blind to the 2nd allocation to the two intervention group sub-arms. |
| Primary Purpose: | Supportive Care |
| Official Title: | Assessing Effectiveness of Acupuncture and Integrative Care in Reducing Peri- and Intra-operative Pain and Anxiety in Patients With Gynecological Cancer: A Randomized Controlled Study |
| Actual Study Start Date : | June 24, 2018 |
| Estimated Primary Completion Date : | August 1, 2022 |
| Estimated Study Completion Date : | December 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Control
Control group include participants randomly allocated to supportive care (with no added integrative care or acupuncture)
|
|
|
Experimental: Touch/relaxation
Touch/relaxation treatment (pre-operative)
|
Other: Acupuncture and touch/relaxation
Pre-operative integrative care (touch-relaxation) that follows with intra-operative acupuncture |
|
Experimental: Acupuncture and touch/relaxation
Acupuncture (intra operative) and touch-relaxation treatment (pre-operative)
|
Other: Acupuncture and touch/relaxation
Pre-operative integrative care (touch-relaxation) that follows with intra-operative acupuncture |
- Pain assessment change [ Time Frame: Change from pre- (1 hour before) to post-operative (24 hours following surgery) ]Pain assessment on a visual analogue scale
- Anxiety assessment change [ Time Frame: Change from pre- (1 hour before) to post-operative (24 hours following surgery) ]Anxiety assessment on a visual analogue scale
- Reduced analgesics use [ Time Frame: During surgery (4-6 hours) and 24-hour post-surgery ]Monitoring intra- and post-operative analgesia use
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Patients undergoing gynecologic-oncology surgery |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria: Female patients age ≥ 18 years, who were referred to surgery for suspected/established gynecological-oncology cancer at the Carmel Medical Center; Patients diagnosed with class1-3 peri-operative risk according to American Society of Anesthesia.
Exclusion Criteria:Unwillingness to sign the research participation form and/or limitations in comprehending the informed consent; during pregnancy; patients with chronic pain treated with opiates within one month preceding surgery.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03560388
| Contact: Eran Ben-Arye, MD | 0528709282 | eranben@netvision.net.il | |
| Contact: Ofer Lavi, MD | lavi_ofer@clalit.org.il |
| Israel | |
| Carmel Medical center | Recruiting |
| Haifa, Israel, 35152 | |
| Contact: Eran Ben-Arye, MD 972528709282 ext 0 eranbe@clalit.org.il | |
| Principal Investigator: Eran Ben-Arye | |
| Principal Investigator: | Eran Ben-Arye, MD | Clalit Health Services |
| Responsible Party: | Eran Ben-Arye, Clinical Associate Professor, Carmel Medical Center |
| ClinicalTrials.gov Identifier: | NCT03560388 |
| Other Study ID Numbers: |
CMC-18-0037-CTIL |
| First Posted: | June 18, 2018 Key Record Dates |
| Last Update Posted: | August 3, 2021 |
| Last Verified: | August 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Integrative medicine Acupuncture Gynecological oncology Surgery |
Analgesia Pain Anxiety |

